Zydus Hospira Oncology

Zydus Hospira Oncology Private Limited (ZHOPL) is a specialized pharmaceutical company focused on the manufacturing of oncology medicines. Originally established as a joint venture between Zydus Lifesciences and Hospira (now part of Pfizer), the company operates a world-class manufacturing plant in Ahmedabad, India, dedicated to cytotoxic injectables. The facility is designed to meet stringent global regulatory standards, supplying critical cancer treatments to markets in the United States, Europe, and beyond. In 2017, Zydus Lifesciences acquired the remaining 50% stake from Hospira, making it a wholly-owned subsidiary. The company remains a key component of Zydus's global oncology strategy, producing high-quality generic chemotherapy agents.